Production (Stage)
BetterLife Pharma Inc.
BETRF
$0.0725
$0.008413.11%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -148.80K | -517.70K | 440.60K | -1.05M | -1.43M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -159.60K | -394.40K | -419.50K | 223.90K | 1.17M |
| Change in Net Operating Assets | 298.40K | 898.60K | -125.20K | 95.90K | -371.50K |
| Cash from Operations | -10.00K | -13.50K | -104.00K | -731.40K | -633.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 1.22M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.00K | 8.70K | 34.40K | 705.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | 20.20K |
| Cash from Financing | 17.60K | 6.10K | 25.20K | 514.90K | 917.10K |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.60K | -7.40K | -78.80K | -216.60K | 284.10K |